Balancing Efficacy and Bleeding Risk in the Prevention of Stroke Due to Atrial Fibrillation with Newer Oral Anticoagulants

With the evaluation and approval of newer oral anticoagulants such as the factor IIa inhibitor, dabigatran etexilate and the factor Xa inhibitors, rivaroxaban and apixaban, strategies for stroke prevention in atrial fibrillation need a thorough re-evaluation of current options. Clinicians are natura...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Agarwal, M. B., Verma, Subhash, Mahapatra, Manoranjan, Tripathi, A. K., Bhave, Abhay, Deshpande, Anand, Vora, Amit, Dalal, Jamshed J., Shah, A. B., Bichu, S.
Formato: Artigo
Idioma:Inglês
Publicado em: Springer-Verlag 2012
Assuntos:
Review Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3422392/
https://ncbi.nlm.nih.gov/pubmed/23997448
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s12288-012-0167-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados